文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急性肾损伤风险预测模型的系统评价与Meta分析

Characterization of Risk Prediction Models for Acute Kidney Injury: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Netw Open · 2023-05-01
一句话结论150项研究、1440万参与者的系统评价显示,已发表的急性肾损伤预测模型总体C统计量为0.80,但异质性极高且84.4%模型存在高偏倚风险,限制临床应用。

该研究系统检索MEDLINE(1946年1月至2021年4月)和Embase(1947年1月至2021年4月),纳入所有开发急性肾损伤预测模型(至少2个预测变量)的研究,共150项研究、1440万参与者。采用随机效应模型合并C统计量,并按4种临床场景进行亚组分析,总体合并C统计量为0.80(95%CI 0.79-0.81),各亚组范围为0.78-0.82。研究间异质性高(如造影剂相关急性肾损伤I²=99.9%,P<.001),84.4%的模型存在高偏倚风险。作者认为预测模型区分度良好,但临床场景、人群和预测变量的差异导致高度异质性,限制了临床实用性,亟需标准化的开发和验证流程。

要点

  • 150项研究、1440万参与者中,急性肾损伤预测模型的总体合并C统计量为0.80(95%CI 0.79-0.81),区分度良好。
  • 不同临床场景的合并C统计量范围为0.78(95%CI 0.75-0.80)至0.82(95%CI 0.78-0.86)。
  • 研究间异质性高,造影剂相关急性肾损伤亚组I²=99.9%(P<.001),多种方法未发现明确异质性来源。
  • 126个模型(84.4%)根据预测模型偏倚风险评估工具存在高偏倚风险。
  • 作者认为临床场景、人群和预测变量的广泛差异导致高度异质性,限制了模型的临床实用性,亟需标准化开发和验证流程。

适用人群与场景

  • 所有开发急性肾损伤预测模型的研究,不限制研究人群或方法学设计。

诊断标准与关键阈值

  • 急性肾损伤预测模型定义为包含至少2个预测变量、用于估计未来发生急性肾损伤的统计模型。

研究设计与关键结果

  • 系统评价与Meta分析:检索MEDLINE(1946年1月至2021年4月)和Embase(1947年1月至2021年4月),初检6955项研究,最终纳入150项研究、1440万参与者。
  • 研究设计、人群、急性肾损伤定义和模型性能评估方法差异很大;总体合并C统计量为0.80(95%CI 0.79-0.81)。
  • 不同临床亚组的合并C统计量范围为0.78(95%CI 0.75-0.80)至0.82(95%CI 0.78-0.86)。
  • 研究间异质性总体高,各临床场景也高(如造影剂相关急性肾损伤:I²=99.9%;P<.001),多种方法未发现明确异质性来源。
  • 根据预测模型偏倚风险评估工具,126个模型(84.4%)存在高偏倚风险。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,遵循PRISMA指南,采用随机效应模型合并数据。
  • 局限:研究设计、人群、急性肾损伤定义和模型性能评估方法差异很大;研究间异质性高(如造影剂相关急性肾损伤I²=99.9%;P<.001),多种方法未发现明确异质性来源;84.4%的模型存在高偏倚风险;作者认为亟需标准化的开发和验证流程。

对床旁实践的改变

  • 作者认为已发表急性肾损伤预测模型的区分度良好(总体合并C统计量0.80),但临床场景、人群和预测变量的广泛差异导致高度异质性,限制了临床实用性。
  • 作者认为亟需标准化的预测模型开发和验证流程。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Despite the expansion of published prediction models for acute kidney injury (AKI), there is little evidence of uptake of these models beyond their local derivation nor data on their association with patient outcomes.

OBJECTIVE: To systematically review published AKI prediction models across all clinical subsettings.

DATA SOURCES: MEDLINE via PubMed (January 1946 to April 2021) and Embase (January 1947 to April 2021) were searched using medical subject headings and text words related to AKI and prediction models.

STUDY SELECTION: All studies that developed a prediction model for AKI, defined as a statistical model with at least 2 predictive variables to estimate future occurrence of AKI, were eligible for inclusion. There was no limitation on study populations or methodological designs.

DATA EXTRACTION AND SYNTHESIS: Two authors independently searched the literature, screened the studies, and extracted and analyzed the data following the Preferred Reporting Items for Systematic Review and Meta-analyses guideline. The data were pooled using a random-effects model, with subgroups defined by 4 clinical settings. Between-study heterogeneity was explored using multiple methods, and funnel plot analysis was used to identify publication bias.

MAIN OUTCOMES AND MEASURES: C statistic was used to measure the discrimination of prediction models.

RESULTS: Of the 6955 studies initially identified through literature searching, 150 studies, with 14.4 million participants, met the inclusion criteria. The study characteristics differed widely in design, population, AKI definition, and model performance assessments. The overall pooled C statistic was 0.80 (95% CI, 0.79-0.81), with pooled C statistics in different clinical subsettings ranging from 0.78 (95% CI, 0.75-0.80) to 0.82 (95% CI, 0.78-0.86). Between-study heterogeneity was high overall and in the different clinical settings (eg, contrast medium-associated AKI: I2 = 99.9%; P < .001), and multiple methods did not identify any clear sources. A high proportion of models had a high risk of bias (126 [84.4%]) according to the Prediction Model Risk Of Bias Assessment Tool.

CONCLUSIONS AND RELEVANCE: In this study, the discrimination of the published AKI prediction models was good, reflected by high C statistics; however, the wide variation in the clinical settings, populations, and predictive variables likely drives the highly heterogenous findings that limit clinical utility. Standardized procedures for development and validation of prediction models are urgently needed.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Feng Y, Wang AY, Jun M, et al. Characterization of Risk Prediction Models for Acute Kidney Injury: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023. PMID: 37184837. doi:10.1001/jamanetworkopen.2023.13359

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。